Dextrose + Potassium Chloride + Sodium Chloride
Fixed-dose combination
This page lists brands whose active-ingredient set is exactly the combination below. It is identity information only — a fixed-dose combination is not the same product as its single ingredients, and the brand names are not interchangeable across markets.
Not medical advice. Check the pack and the exact composition before comparing products; ask a pharmacist if unsure.
Active ingredients
- Dextrose
dextrose - Potassium Chloride
potassium-chloride - Sodium Chloride
sodium-chloride
Brands with this exact combination
| Brand | Dose | Manufacturer |
|---|---|---|
| DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, and POTASSIUM CHLORIDEUS | 50,000 mg / 2,250 mg / 1,490 mg / 4,500 mg / 2,240 mg / 2,980 mg | Fresenius Kabi USA, LLC |
| Potassium Chloride, Dextrose Monohydrate and Sodium ChlorideUS | 150 mg / 5,000 mg / 450 mg / 900 mg / 75 mg / 200 mg | Baxter Healthcare Company |
| POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE USPCA | 50 mg / 4.5 mg / 1.5 mg / 3 mg | BAXTER CORPORATION |
| POTASSIUM CHLORIDE IN 3.3% DEXTROSE AND 0.3% SODIUM CHLORIDE USPCA | 33 mg / 3 mg / 1.5 mg | BAXTER CORPORATION |
| "信東" 0.298%氯化鉀/(5%葡萄糖及0.9%氯化鈉)注射液TW | — | 信東生技股份有限公司 |
| POTASSIUM CHLORIDE 20 MEQ IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDECA | 50 mg / 4.5 mg / 1.49 mg | ICU MEDICAL CANADA INC |
| POTASSIUM CHLORIDE 20 MEQ IN 5% DEXTROSE AND 0.225% SODIUM CHLORIDECA | 50 mg / 2.25 mg / 1.49 mg | ICU MEDICAL CANADA INC |
| POTASSIUM CHLORIDE 40 MEQ IN 3.3% DEXTROSE AND 0.3% SODIUM CHLORIDECA | 33 mg / 3 mg / 2.98 mg | ICU MEDICAL CANADA INC |
| POTASSIUM CHLORIDE 20 MEQ IN 3.3% DEXTROSE AND 0.3% SODIUM CHLORIDECA | 33 mg / 3 mg / 1.49 mg | ICU MEDICAL CANADA INC |
| POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.2% SODIUM CHLORIDE USPCA | 50 mg / 2 mg / 1.5 mg | BAXTER CORPORATION |
| POTASS CHLOR 40MEQ 5% DEX AND 0.2% SOD CHLORCA | 50 mg / 3 mg / 2 mg | BAXTER CORPORATION |
| POTASSIUM CHLORIDE 40 MEQ IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDECA | 50 mg / 3 mg / 4.5 mg | ICU MEDICAL CANADA INC |
| POTASS CHLOR 10MEQ 5% DEX AND 0.2% SOD CHLORCA | 50 mg / 2 mg / 0.75 mg | BAXTER CORPORATION |
| POTAS CHLOR 30MEQ 5% DEX AND 0.2% SOD CHLORCA | 50 mg / 2.24 mg / 2 mg | BAXTER CORPORATION |
| POTASSIUM 20MEQ 5% DEXTROSE AND 0.33% SODIUM CHLORIDECA | 50 mg / 3.3 mg / 1.5 mg | BAXTER CORPORATION |
| POTASS CHLOR 30MEQ 5% DEX AND 0.33% SOD CHLORCA | 50 mg / 3.3 mg / 2.24 mg | BAXTER CORPORATION |
| POTASS CHLOR 40MEQ 5% DEX AND 0.33% SOD CHLORCA | 3 mg / 50 mg / 3.3 mg | BAXTER CORPORATION |
| POTASS CHLOR 30MEQ 5% DEX AND 0.45% SOD CHLORCA | 50 mg / 4.5 mg / 2.24 mg | BAXTER CORPORATION |
| POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.9% SODIUM CHLORIDE USPCA | 50 mg / 9 mg / 1.5 mg | BAXTER CORPORATION |
| POTASS CHLOR 40MEQ 5% DEX AND 0.9% SOD CHLORCA | 50 mg / 9 mg / 3 mg | BAXTER CORPORATION |
| POTASS CHLORIDE 5% DEXTR 0.45% SOD CHLORCA | 50 mg / 4.5 mg / 0.75 mg | BAXTER CORPORATION |
| 0.15% POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDECA | 50 mg / 4.5 mg / 1.5 mg | B. BRAUN MEDICAL INC |
| 0.30% POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDECA | 50 mg / 4.5 mg / 3 mg | B. BRAUN MEDICAL INC |
| 0.15% POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.20% SODIUM CHLORIDE USPCA | 50 mg / 2 mg / 1.5 mg | B. BRAUN MEDICAL INC |
| 0.15% POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.33% SODIUM CHLORIDE USPCA | 50 mg / 3.3 mg / 1.5 mg | B. BRAUN MEDICAL INC |
| 0.15% POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.9% SODIUM CHLORIDECA | 50 mg / 9 mg / 1.5 mg | B. BRAUN MEDICAL INC |
| 0.15% POTASSIUM CHLORIDE IN 3.3% DEXTROSE AND 0.30% SODIUM CHLORIDECA | 33 mg / 3 mg / 1.5 mg | B. BRAUN MEDICAL INC |
| POTASSIUM CHLORIDE 20 MEQ IN 5% DEXTROSE AND 0.9% SODIUM CHLORIDECA | 1.5 mg / 9 mg / 50 mg | ICU MEDICAL CANADA INC |
| POTASSIUM CHLORIDE 40 MEQ IN 5% DEXTROSE AND 0.9% SODIUM CHLORIDECA | 3 mg / 9 mg / 50 mg | ICU MEDICAL CANADA INC |
| 博特西糖鹽注射液０．１５/５．０/０．４５TW | — | 永豐製藥股份有限公司 |
| POTACIL-DS INJECTION 0.15/5.0/0.45TW | — | 永豐製藥股份有限公司 |
| 博特西糖鹽注射液０．０７５/５．０/０．４５TW | — | 永豐製藥股份有限公司 |
| POTACIL-DS INJECTION 0.075/5.0/0.45TW | — | 永豐製藥股份有限公司 |
| 0.298% KCl in 5% Dextrose and 0.9% NaCl Injection "TBC"TW | — | 信東生技股份有限公司 |
| 0.745% KCl in 5% Dextrose and 0.33% NaCl Injection "TBC"TW | — | 信東生技股份有限公司 |
| 0.149% KCl in 5% Dextrose and 0.33% NaCl Injection "TBC"TW | — | 信東生技股份有限公司 |
| 0.149% KCl in 5% Dextrose and 0.9% NaCl Injection "TBC"TW | — | 信東生技股份有限公司 |
| Potassium Chloride 0.30% in Dextrose 5% and Sodium Chloride 0.45% Injection USPSG | 3,000 mg / 4,500 mg | B. BRAUN SINGAPORE PTE LTD |
| Potassium Chloride 0.22% in Dextrose 5% and Sodium Chloride 0.45% Injection USPSG | 2,200 mg / 4,500 mg | B. BRAUN SINGAPORE PTE LTD |
| Potassium Chloride 0.15% in Dextrose 5% and Sodium Chloride 0.9% Injection USPSG | 1,500 mg / 9,000 mg | B. BRAUN SINGAPORE PTE LTD |
| Potassium Chloride 0.15% in Dextrose 5% and Sodium Chloride 0.45% Injection USPSG | 1,500 mg / 4,500 mg | B. BRAUN SINGAPORE PTE LTD |
| 10 mEq Potassium Chloride in 5% Dextrose and 0.33% Sodium Chloride Injection, USPSG | 50 g/L / 1.5 g/L / 3.3 g/L | BAXTER HEALTHCARE (ASIA) PTE LTD |
Same combination in other markets
No product with this combination is recorded in the other covered markets yet.
Only the main ingredient is the same — this is NOT the same fixed-dose combination. View the main ingredient
See warnings for these ingredients
Source & licence: built from the same regulator data as the ingredient pages (openFDA, dm+d, CIMA, COFEPRIS, PBS/TGA, Health Canada DPD, NHSA). Facts only; see the licence register.